These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir. Quenelle DC; Collins DJ; Kern ER Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus. Smee DF; Hurst BL; Wong MH; Glazer RI; Rahman A; Sidwell RW Antiviral Res; 2007 Nov; 76(2):124-9. PubMed ID: 17658623 [TBL] [Abstract][Full Text] [Related]
7. Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201). Smee DF; Wong MH; Russell A; Ennis J; Turner JD PLoS One; 2011; 6(10):e26330. PubMed ID: 22022603 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of cidofovir in a murine model of disseminated progressive vaccinia. Neyts J; Leyssen P; Verbeken E; De Clercq E Antimicrob Agents Chemother; 2004 Jun; 48(6):2267-73. PubMed ID: 15155231 [TBL] [Abstract][Full Text] [Related]
9. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice. Smee DF; Wandersee MK; Bailey KW; Wong MH; Chu CK; Gadthula S; Sidwell RW Antiviral Res; 2007 Jan; 73(1):69-77. PubMed ID: 16712967 [TBL] [Abstract][Full Text] [Related]
10. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719 [TBL] [Abstract][Full Text] [Related]
11. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Smee DF; Bailey KW; Wong MH; Sidwell RW Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188 [TBL] [Abstract][Full Text] [Related]
13. Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus. Zaitseva M; McCullough KT; Cruz S; Thomas A; Diaz CG; Keilholz L; Grossi IM; Trost LC; Golding H J Virol; 2015 Mar; 89(6):3295-307. PubMed ID: 25589648 [TBL] [Abstract][Full Text] [Related]
14. Topical treatment with BV-araU of immunosuppressed and immunocompetent shaved mice cutaneously infected with herpes simplex virus type 1. Ijichi K; Ashida N; Varia S; Machida H Antiviral Res; 1993 May; 21(1):47-57. PubMed ID: 8391248 [TBL] [Abstract][Full Text] [Related]
15. Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection. Knorr CW; Allen SD; Torres AR; Smee DF Antiviral Res; 2006 Nov; 72(2):125-33. PubMed ID: 16782209 [TBL] [Abstract][Full Text] [Related]
16. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice. Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. Neyts J; De Clercq E J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505 [TBL] [Abstract][Full Text] [Related]
18. Ceragenins: a class of antiviral compounds to treat orthopox infections. Howell MD; Streib JE; Kim BE; Lesley LJ; Dunlap AP; Geng D; Feng Y; Savage PB; Leung DY J Invest Dermatol; 2009 Nov; 129(11):2668-75. PubMed ID: 19516269 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous viral infections in organ transplant patients. Piaserico S; Sandini E; Peserico A; Alaibac M G Ital Dermatol Venereol; 2014 Aug; 149(4):409-15. PubMed ID: 25068228 [TBL] [Abstract][Full Text] [Related]
20. Topical treatment of warts and mollusca with imiquimod. Hengge UR; Goos M; Arndt R Ann Intern Med; 2000 Jan; 132(1):95. PubMed ID: 10627266 [No Abstract] [Full Text] [Related] [Next] [New Search]